Actuate Therapeutics Inc

NASDAQ: ACTU · Real-Time Price · USD
8.00
-0.22 (-2.68%)
At close: Aug 15, 2025, 3:59 PM
8.12
1.56%
After-hours: Aug 15, 2025, 04:10 PM EDT

Actuate Therapeutics Inc Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Cash & Equivalents
8.64M 2.96M 20.45M
Short-Term Investments
n/a n/a n/a
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
110.55K n/a n/a
Receivables
n/a n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
566.28K 36.91K 33.75K
Total Current Assets
9.21M 3M 20.48M
Property-Plant & Equipment
n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
110.55K n/a n/a
Total Assets
9.32M 3M 20.48M
Account Payables
1.92M 3.42M 2.13M
Deferred Revenue
n/a n/a n/a
Short-Term Debt
n/a n/a n/a
Other Current Liabilities
888.45K 277.5K 132.03K
Total Current Liabilities
8.8M 6.92M 4.34M
Long-Term Debt
n/a n/a n/a
Other Long-Term Liabilities
411.76K 95.7M 91.44M
Total Long-Term Liabilities
411.76K 95.7M 91.44M
Total Liabilities
9.21M 102.62M 95.79M
Total Debt
n/a n/a n/a
Common Stock
20.00 2.00 2.00
Retained Earnings
-132.38M -105.09M -80.35M
Comprehensive Income
n/a -0.00 n/a
Shareholders Equity
104.19K -99.63M -75.31M
Total Investments
n/a n/a n/a